Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment

P. Cordiali-Fei, M. Ardigò, A. Mastroianni, A. Giuliani, G. D'Agosto, V. Bordignon, E. Trento, A. Vento, Enzo Berardesca

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The purpose of this study is to evaluate blood cytokines and immunological parameters in psoriatic patients during long-term treatment with etanercept. Forty-five subjects of both sexes affected by psoriasis with or without arthritis entered the study and were treated with etanercept according to international standard protocols. Biochemical blood analysis was carried out at baseline and during follow-up every second month. In particular, the following parameters were kept under control: antinuclear antibodies, anti-nDNA antibodies, anti-histone antibodies, blood cell count, circulating lymphocyte subtypes (CD3, CD4, CD8, CD16, CD19) and IgE. Cytokine profiles (IL-1-α, IL-1-β, IL-6, IL-8, IL-10, IL-12, INF, TNF-α) were also evaluated in blood samples during the treatment up to 1 year of follow-up. A significant decrease in PASI score (p

Original languageEnglish
Pages (from-to)643-649
Number of pages7
JournalInternational Journal of Immunopathology and Pharmacology
Volume21
Issue number3
Publication statusPublished - Jul 2008

Fingerprint

Cytokines
Interleukin-1
Anti-Idiotypic Antibodies
Serum
Blood Cell Count
Antinuclear Antibodies
Interleukin-12
Interleukin-8
Psoriasis
Interleukin-10
Histones
Immunoglobulin E
Arthritis
Interleukin-6
Therapeutics
Lymphocytes
Etanercept

Keywords

  • Cytokines
  • Etanercept
  • II-1
  • II-12
  • INF-gamma
  • Long-term treatment
  • Psoriasis
  • TNF-alpha

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment. / Cordiali-Fei, P.; Ardigò, M.; Mastroianni, A.; Giuliani, A.; D'Agosto, G.; Bordignon, V.; Trento, E.; Vento, A.; Berardesca, Enzo.

In: International Journal of Immunopathology and Pharmacology, Vol. 21, No. 3, 07.2008, p. 643-649.

Research output: Contribution to journalArticle

@article{9855035014d74a428897b59e9c0ab082,
title = "Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment",
abstract = "The purpose of this study is to evaluate blood cytokines and immunological parameters in psoriatic patients during long-term treatment with etanercept. Forty-five subjects of both sexes affected by psoriasis with or without arthritis entered the study and were treated with etanercept according to international standard protocols. Biochemical blood analysis was carried out at baseline and during follow-up every second month. In particular, the following parameters were kept under control: antinuclear antibodies, anti-nDNA antibodies, anti-histone antibodies, blood cell count, circulating lymphocyte subtypes (CD3, CD4, CD8, CD16, CD19) and IgE. Cytokine profiles (IL-1-α, IL-1-β, IL-6, IL-8, IL-10, IL-12, INF, TNF-α) were also evaluated in blood samples during the treatment up to 1 year of follow-up. A significant decrease in PASI score (p",
keywords = "Cytokines, Etanercept, II-1, II-12, INF-gamma, Long-term treatment, Psoriasis, TNF-alpha",
author = "P. Cordiali-Fei and M. Ardig{\`o} and A. Mastroianni and A. Giuliani and G. D'Agosto and V. Bordignon and E. Trento and A. Vento and Enzo Berardesca",
year = "2008",
month = "7",
language = "English",
volume = "21",
pages = "643--649",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "3",

}

TY - JOUR

T1 - Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment

AU - Cordiali-Fei, P.

AU - Ardigò, M.

AU - Mastroianni, A.

AU - Giuliani, A.

AU - D'Agosto, G.

AU - Bordignon, V.

AU - Trento, E.

AU - Vento, A.

AU - Berardesca, Enzo

PY - 2008/7

Y1 - 2008/7

N2 - The purpose of this study is to evaluate blood cytokines and immunological parameters in psoriatic patients during long-term treatment with etanercept. Forty-five subjects of both sexes affected by psoriasis with or without arthritis entered the study and were treated with etanercept according to international standard protocols. Biochemical blood analysis was carried out at baseline and during follow-up every second month. In particular, the following parameters were kept under control: antinuclear antibodies, anti-nDNA antibodies, anti-histone antibodies, blood cell count, circulating lymphocyte subtypes (CD3, CD4, CD8, CD16, CD19) and IgE. Cytokine profiles (IL-1-α, IL-1-β, IL-6, IL-8, IL-10, IL-12, INF, TNF-α) were also evaluated in blood samples during the treatment up to 1 year of follow-up. A significant decrease in PASI score (p

AB - The purpose of this study is to evaluate blood cytokines and immunological parameters in psoriatic patients during long-term treatment with etanercept. Forty-five subjects of both sexes affected by psoriasis with or without arthritis entered the study and were treated with etanercept according to international standard protocols. Biochemical blood analysis was carried out at baseline and during follow-up every second month. In particular, the following parameters were kept under control: antinuclear antibodies, anti-nDNA antibodies, anti-histone antibodies, blood cell count, circulating lymphocyte subtypes (CD3, CD4, CD8, CD16, CD19) and IgE. Cytokine profiles (IL-1-α, IL-1-β, IL-6, IL-8, IL-10, IL-12, INF, TNF-α) were also evaluated in blood samples during the treatment up to 1 year of follow-up. A significant decrease in PASI score (p

KW - Cytokines

KW - Etanercept

KW - II-1

KW - II-12

KW - INF-gamma

KW - Long-term treatment

KW - Psoriasis

KW - TNF-alpha

UR - http://www.scopus.com/inward/record.url?scp=53749101805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749101805&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 643

EP - 649

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 3

ER -